AHCO
AdaptHealth Corp.
-0.13 (-2.28%)5.78USD664K成交股數787M市值–本益比(近四季)0.2股價營收比+12.7%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 740M+13% | 820M+5% | 990M+23% | 820M+2% | 657M-17% | 778M-9% | 806M+0% | 806M+2% | 792M | 858M | 804M | 793M |
| 營業成本 | 636M | 708M | 799M | 658M | 521M | 657M | 644M | 637M | 635M | 554M | 693M | 673M |
| 毛利 | 104M-23% | 112M-7% | 191M+18% | 162M-4% | 136M-14% | 120M-60% | 162M+47% | 169M+41% | 157M | 304M | 111M | 120M |
| 毛利率 | 14.1% | 13.6% | 19.3% | 19.7% | 20.7% | 15.5% | 20.1% | 21.0% | 19.9% | 35.5% | 13.7% | 15.1% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 96.1M | 95.9M | 110M | 90.1M | 95.3M | 86.9M | 87.3M | 99.4M | 89.0M | 192M | 45.2M | 50.1M |
| 營業利益 | −138M-310% | 5.5M-76% | −59.7M-194% | 61.7M+19% | 65.7M+30% | 23.2M-111% | 63.5M-114% | 52.0M-4% | 50.5M | −218M | −461M | 54.3M |
| 營業利益率 | -18.6% | 0.7% | -6.0% | 7.5% | 10.0% | 3.0% | 7.9% | 6.5% | 6.4% | -25.4% | -57.3% | 6.8% |
| 稅後淨利 | −134M-1013% | −16.0M+123% | −103M-550% | 24.5M+26% | 14.7M-788% | −7.2M-97% | 22.9M-105% | 19.4M+39% | −2.1M | −255M | −454M | 14.0M |
| 淨利率 | -18.1% | -2.0% | -10.4% | 3.0% | 2.2% | -0.9% | 2.8% | 2.4% | -0.3% | -29.7% | -56.5% | 1.8% |
| 稀釋 EPS | -0.99-1090% | -0.12+140% | -0.73-587% | 0.16+23% | 0.10-600% | -0.05-97% | 0.15-104% | 0.13+44% | -0.02 | -1.91 | -3.43 | 0.09 |
| 稀釋股數 | 136M | 136M | 135M | 137M | 137M | 135M | 137M | 136M | 133M | 134M | 135M | 136M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | – | 48.0M | 106M | 80.4M | 68.6M | 53.7M | 100M | 69.8M | 79.6M | 77.1M | 56.1M | 45.1M |
| 應收帳款 | 390M | 392M | 371M | 380M | 394M | 418M | 401M | 437M | 430M | 389M | 371M | 366M |
| 存貨 | 105M | 159M | 115M | 149M | 149M | 129M | 133M | 124M | 109M | 114M | 116M | 115M |
| 總資產 | 4.3B | 4.4B | 4.3B | 4.4B | 4.4B | 4.4B | 4.5B | 4.5B | 4.5B | 4.5B | 4.7B | 5.2B |
| 有息負債 | 1.9B | 1.8B | 1.7B | 1.7B | 1.8B | 1.9B | 2.0B | 2.0B | 2.2B | 2.1B | 2.1B | 2.1B |
| 總負債 | 3.0B | 2.9B | 2.8B | 2.8B | 2.8B | 2.9B | 2.9B | 3.0B | 3.0B | 3.0B | 3.0B | 3.0B |
| 股東權益 | 1.4B | 1.5B | 1.5B | 1.6B | 1.6B | 1.6B | 1.5B | 1.5B | 1.5B | 1.5B | 1.7B | 2.2B |
| 負債比 | 68.1% | 65.8% | 64.6% | 62.9% | 63.4% | 64.5% | 65.9% | 66.9% | 67.3% | 67.5% | 63.2% | 58.0% |
| 淨現金(現金 − 有息負債) | – | −1.8B | −1.6B | −1.7B | −1.7B | −1.9B | −1.9B | −2.0B | −2.1B | −2.0B | −2.1B | −2.1B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 93.7M-2% | – | – | – | 95.5M | – | – | 49.0M | – | – | – |
| 資本支出 | – | 121M | – | – | – | 95.6M | – | – | 87.9M | – | – | – |
| 自由現金流 | – | −27.5M+47297% | – | – | – | −58K | – | – | −38.9M | – | – | – |
| 折舊攤銷 | – | 106M | – | – | – | 94.3M | – | – | 92.9M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -3.4% | – | – | – | -0.0% | – | – | -4.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.2B
| Sleep Health | 1.4B | 42.5% | +2.1% |
|---|---|---|---|
| Respiratory Health | 691M | 21.3% | +6.1% |
| Diabetes Health | 592M | 18.3% | -3.6% |
| Wellness At Home | 583M | 18.0% | -9.8% |
主要客戶2025 年度 · 3.2B
| Insurance Payor | 2.0B | 60.5% | -1.8% |
|---|---|---|---|
| Government Payor | 853M | 26.3% | +1.2% |
| Patient Payor | 429M | 13.2% | +2.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.2B | -0.5% | −70.8M | -2.2% | -0.52 | 219M |
| FY2024 | 3.3B | +1.9% | 90.4M | 2.8% | 0.61 | 236M |
| FY2023 | 3.2B | +7.7% | −679M | -21.2% | -5.31 | 143M |
| FY2022 | 3.0B | +21.0% | 69.3M | 2.3% | 0.33 | −17.6M |
| FY2021 | 2.5B | +132.4% | 156M | 6.4% | 0.67 | 72.4M |
| FY2020 | 1.1B | +99.5% | −162M | -15.3% | -3.08 | 156M |
| FY2019 | 530M | +53.4% | −21.3M | -4.0% | -0.95 | 39.1M |
| FY2018 | 345M | – | 23.3M | 6.7% | 1.95 | 58.5M |